Key result
This article reviews the pharmacological and surgical management of angina and coronary artery disease in patients with heart failure according to the European Society of Cardiology guidelines.
Answers are grounded in this paper and cite their sources.
This review summarizes the pharmacological and surgical management of angina and coronary artery disease in patients with heart failure according to the European Society of Cardiology guidelines.
Co-morbidities are particularly relevant in the management of HF as they may confound HF diagnosis, worsen symptomatology, impact quality of life and aggravate the prognosis. According to the most recent European Society of Cardiology (ESC) guidelines, treatment of co- morbidities is an essential element of the comprehensive care of HF. Angina and coronary artery disease (CAD), in particular are common disorders associated with HF. The pharmacological and surgical management of angina according to the ESC guidelines is reviewed in this article.
No takes yet. Share an insight, caveat, or question.
Spoletini et al. (2017) conducted a review in Heart failure with angina and coronary artery disease. Pharmacological and surgical management of angina was evaluated. This article reviews the pharmacological and surgical management of angina and coronary artery disease in patients with heart failure according to the European Society of Cardiology guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: